查看完整行情页>>
|
货币单位:美元(USD)
Theravance Biopharma, Inc. (tbph)
| 开盘价:-- |
最高价:-- |
最低价:-- |
52周最高价:-- |
52周最低价:-- |
| 成交量:-- |
平均成交量:-- |
市值:-- |
市盈率:-- |
预期市盈率:-- |
| 每股收益:-- |
贝塔系数:-- |
股息:-- |
收益率:-- |
总股本:-- |
| 机构持股 |
| 持有者 |
持有份额 |
持股比例 |
份额变化 |
变化率 |
报告日期 |
| Geode Capital Management, LLC |
1010163 |
1.33% |
-31669 |
-3.04% |
2022-03-31
|
| Madison Avenue Partners, LP |
7269584 |
9.55% |
621559 |
9.35% |
2022-03-31
|
| Vanguard Group Inc |
6947947 |
9.13% |
648124 |
10.29% |
2022-03-31
|
| Weiss Asset Management LP |
5412487 |
7.11% |
2810709 |
108.03% |
2022-03-31
|
| BlackRock Inc |
5002363 |
6.57% |
-102096 |
-2.00% |
2021-12-31
|
| ODRE 2005 SL |
4108318 |
5.40% |
4108318 |
-- |
2022-03-18
|
| Orbimed Advisors, LLC |
3254713 |
4.28% |
-2719822 |
-45.52% |
2022-03-31
|
| BlackRock Fund Advisors |
2698640 |
3.55% |
-71683 |
-2.59% |
2022-05-31
|
| FMR Inc |
2694912 |
3.54% |
106531 |
4.12% |
2022-03-31
|
| Fidelity Management & Research Company LLC |
2278921 |
2.99% |
-1656070 |
-42.09% |
2022-05-31
|
| Vanguard Investments Australia Ltd |
1741346 |
2.29% |
-280 |
-0.02% |
2022-05-31
|
| State Street Corporation |
1541533 |
2.03% |
181331 |
13.33% |
2022-03-31
|
| Newtyn Management LLC |
1375000 |
1.81% |
375000 |
37.50% |
2022-03-31
|
| Woodline Partners LP |
1326653 |
1.74% |
751540 |
130.68% |
2022-03-31
|
| D. E. Shaw & Co LP |
1239042 |
1.63% |
362579 |
41.37% |
2022-03-31
|
| Chescapmanager LLC |
1166574 |
1.53% |
-95100 |
-7.54% |
2022-03-31
|
| Fidelity Management Trust Company |
1128671 |
1.48% |
6487 |
0.58% |
2022-05-31
|
| Jacobs Levy Equity Management, Inc. |
1041954 |
1.37% |
19026 |
1.86% |
2022-03-31
|
| Baupost Group LLC |
13643333 |
17.92% |
-16835 |
-0.12% |
2022-03-31
|
| Morgan Stanley - Brokerage Accounts |
1479029 |
1.94% |
950477 |
179.83% |
2021-12-31
|
| Northern Trust Investments Inc |
896199 |
1.18% |
-37806 |
-4.05% |
2022-04-30
|
| FMR LLC |
9607310 |
12.66% |
9607310 |
-- |
2020-12-31
|
| Point72 Asset Management, L.P. |
3405602 |
4.56% |
3405602 |
-- |
2021-09-30
|
| State Street Global Advisors |
706482 |
0.96% |
41370 |
6.22% |
2022-02-28
|
| Millennium Management LLC |
945534 |
1.28% |
794983 |
528.05% |
2021-09-30
|
| Camber Capital Management LLC |
2500000 |
3.39% |
2500000 |
-- |
2021-09-30
|
| Rock Springs Capital Management LP |
687500 |
0.93% |
-- |
-- |
2021-09-30
|
| Vanguard |
1858569 |
2.52% |
-100 |
-0.01% |
2021-12-31
|
| Wellington Management Company LLP |
8727324 |
11.88% |
1263122 |
16.92% |
2021-06-30
|
| MAVEN SECURITIES Ltd |
1342574 |
1.83% |
1342574 |
-- |
2021-06-30
|
| LAURION CAPITAL MANAGEMENT LP |
1094936 |
1.49% |
390328 |
55.40% |
2021-06-30
|
| Dafna Capital Management LLC |
732345 |
1.00% |
691180 |
1679.05% |
2021-06-30
|
| Fidelity SelectCo, LLC |
1416736 |
1.92% |
-2459015 |
-63.45% |
2021-10-31
|
| Columbia Wanger Asset Management LLC |
1637426 |
2.23% |
-716261 |
-30.43% |
2021-09-30
|
| Hartford Funds Management Company, LLC |
1348259 |
1.84% |
118314 |
9.62% |
2021-08-31
|
| GlaxoSmithKline PLC |
9644807 |
13.13% |
-1 |
-- |
2020-06-22
|
| Fidelity Management and Research Company |
9469880 |
12.89% |
188372 |
2.03% |
2021-03-31
|
| Wells Fargo Funds Management LLC |
925194 |
1.29% |
249298 |
36.88% |
2021-06-30
|
| Fidelity Management Trust Co |
1558476 |
2.39% |
-16512 |
-1.05% |
2021-04-30
|
| Ameriprise Financial Inc |
1502873 |
2.35% |
-73842 |
-4.68% |
2020-06-30
|
| Fidelity Management & Research Company LLC |
5342259 |
8.35% |
-466029 |
-8.02% |
2020-11-30
|
| JANE STREET GROUP, LLC |
1218912 |
1.91% |
1218912 |
-- |
2020-06-30
|
| Link Fund Solutions Limited |
4836864 |
7.62% |
-414485 |
-7.89% |
2020-03-31
|
| Woodford Investment Management Ltd |
11171980 |
17.59% |
121000 |
1.09% |
2020-07-31
|
| NORGES BANK |
1075589 |
1.90% |
199416 |
22.76% |
2019-12-31
|
| Fidelity Management & Research Company |
5244374 |
9.26% |
-537515 |
-9.30% |
2020-05-31
|
| Perceptive Advisors LLC |
1000000 |
1.77% |
1000000 |
-- |
2020-03-31
|
| Woodford Investment Management LLP |
11350719 |
20.04% |
-809261 |
-6.66% |
2019-09-30
|
| Northern Trust Corp |
571576 |
1.01% |
-6094 |
-1.05% |
2019-12-31
|
| Northern Trust Investments N A |
577670 |
1.02% |
24041 |
4.34% |
2019-09-30
|
| T. Rowe Price Associates, Inc. |
524014 |
0.93% |
-615356 |
-54.01% |
2019-09-30
|
| Woodford Investment Management LLP (Capita) |
878000 |
1.55% |
170000 |
24.01% |
2020-01-31
|
| BlackRock Asset Management Canada Ltd |
1002102 |
1.79% |
44 |
-- |
2019-05-31
|
| Cormorant Asset Management, LLC |
884916 |
1.58% |
-215084 |
-19.55% |
2018-12-31
|
| Consonance Capital Management LP |
731909 |
1.32% |
731909 |
-- |
2018-09-30
|
| BlackRock Institutional Trust Company NA |
1176462 |
2.12% |
24018 |
2.08% |
2018-06-30
|
| First Manhattan Company |
619085 |
1.12% |
-21270 |
-3.32% |
2018-06-30
|
| Armistice Capital, LLC |
1180000 |
2.13% |
1180000 |
-- |
2018-06-30
|
| State Street Corp |
877393 |
1.59% |
15942 |
1.85% |
2018-06-30
|
| State of New Jersey Common Pension Fd D |
225459 |
0.41% |
-- |
-- |
2018-03-31
|
| Charles Schwab Investment Management Inc |
226268 |
0.41% |
17193 |
8.22% |
2018-06-30
|
| BNP Paribas Investment Partners Lux |
205361 |
0.37% |
-28595 |
-12.22% |
2018-07-31
|
| Goldman, Sachs & Co. |
209119 |
0.38% |
-261098 |
-55.53% |
2018-06-30
|
| Fidelity Institutional Asset Management |
152000 |
0.28% |
80000 |
111.11% |
2018-06-30
|
| Foundation Asset Management, LLC |
399537 |
0.73% |
-32995 |
-7.63% |
2018-03-31
|
| TIAA-CREF Investment Management LLC |
124812 |
0.23% |
-1037 |
-0.82% |
2018-03-31
|
| BNY Mellon Investment Management |
128421 |
0.23% |
-4445 |
-3.35% |
2018-03-31
|
| BNP Paribas Investment Partners SA |
176192 |
0.32% |
1368 |
0.78% |
2017-12-31
|
| SENZAR ASSET MANAGEMENT, LLC |
182100 |
0.34% |
182100 |
-- |
2017-09-30
|
| Balyasny Asset Management LLC |
180600 |
0.33% |
24850 |
15.96% |
2017-09-30
|
| Opaleye Management Inc |
180000 |
0.33% |
-- |
-- |
2017-09-30
|
| D. E. Shaw & Co LP |
178707 |
0.33% |
72315 |
67.97% |
2017-06-30
|
| BlackRock Advisors LLC |
135265 |
0.28% |
-3862 |
-2.78% |
2016-09-30
|
| Panagora Asset Management Inc |
165581 |
0.34% |
-46534 |
-21.94% |
2016-09-30
|
| Franklin Advisers Inc |
379800 |
0.77% |
379800 |
-- |
2016-12-31
|
| Blackrock, Inc. |
2034897 |
2.00% |
40555497 |
0.10% |
1999-11-30
|
| Baupost Group, L.L.C |
6061228 |
2.00% |
120800274 |
0.20% |
1999-11-30
|
| 共同基金持股 |
| 持有者 |
持有份额 |
持股比例 |
份额变化 |
变化率 |
报告日期 |
| SPDR |
257069 |
0.34% |
-- |
-- |
2022-05-31
|
| Vanguard Total Stock Market Index Fund |
1732924 |
2.28% |
-- |
-- |
2022-05-31
|
| Worldwide Healthcare |
1678687 |
2.21% |
-264913 |
-13.63% |
2022-02-28
|
| Biotech Growth Trust Plc |
1602230 |
2.11% |
-10330 |
-0.64% |
2022-02-28
|
| Vanguard Small Cap Index |
1486231 |
1.95% |
-3759 |
-0.25% |
2022-05-31
|
| iShares Russell 2000 ETF |
1318232 |
1.73% |
2240 |
0.17% |
2022-05-31
|
| Fidelity Growth Company Commingled Pool |
1128671 |
1.48% |
6487 |
0.58% |
2022-04-30
|
| Vanguard Small Cap Growth Index Fund |
896915 |
1.18% |
8943 |
1.01% |
2022-05-31
|
| Vanguard Extended Market Index Fund |
702127 |
0.92% |
970 |
0.14% |
2022-05-31
|
| Vanguard Explorer Fund |
553403 |
0.73% |
292632 |
112.22% |
2022-03-31
|
| Fidelity |
262352 |
0.34% |
-23209 |
-8.13% |
2022-04-30
|
| Vanguard Strategic Small Cap Equity Fund |
328093 |
0.43% |
-- |
-- |
2022-03-31
|
| State Street Russell Small/Mid Cap |
340938 |
0.45% |
-- |
-- |
2022-05-31
|
| Vanguard Strategic Equity Fund |
389911 |
0.51% |
389911 |
-- |
2022-03-31
|
| iShares Biotechnology ETF |
404807 |
0.53% |
-4480 |
-1.09% |
2022-05-31
|
| Tekla Healthcare Investors |
452402 |
0.59% |
-- |
-- |
2021-12-31
|
| iShares Russell 2000 Growth ETF |
478331 |
0.63% |
-551 |
-0.12% |
2022-05-31
|
| State Street Russell Small Cap |
234355 |
0.31% |
-- |
-- |
2022-03-31
|
| Schwab US Small-Cap ETF |
215703 |
0.29% |
-- |
-- |
2022-02-28
|
| MEDICAL BioHealth |
371184 |
0.50% |
-- |
-- |
2021-10-31
|
| Delaware Healthcare Fund |
208783 |
0.28% |
-- |
-- |
2021-12-31
|
| Tekla Life Sciences Investors |
203894 |
0.28% |
62253 |
43.95% |
2021-06-30
|
| Brighthouse/Wellington Lg Cp Rsrch Port |
385342 |
0.52% |
205305 |
114.03% |
2021-06-30
|
| Fidelity Advisor |
510926 |
0.70% |
-235400 |
-31.54% |
2021-08-31
|
| Candriam Eqs L Biotechnology |
475696 |
0.65% |
-- |
-- |
2021-08-31
|
| Wellington Global Health Care Equity |
1303930 |
1.77% |
-- |
-- |
2021-08-31
|
| iShares Nasdaq Biotechnology ETF |
547259 |
0.84% |
-2466 |
-0.45% |
2021-05-28
|
| Wells Fargo Small Co Gr Port |
360265 |
0.55% |
-15699 |
-4.18% |
2021-01-31
|
| Peregrine Capital Mgt - Small Cap Growth |
360265 |
0.56% |
-15699 |
-4.18% |
2021-01-31
|
| Wells Fargo Small Company Growth Fund |
394675 |
0.62% |
-2267 |
-0.57% |
2020-11-30
|
| Columbia Acorn Fund |
457614 |
0.72% |
-559437 |
-55.01% |
2020-09-30
|
| T. Rowe Price QM US Small-Cap Gr Eq Fd |
333329 |
0.52% |
-- |
-- |
2020-06-30
|
| Wanger USA |
367282 |
0.65% |
-- |
-- |
2020-04-30
|
| LF ASI Income Focus Fund |
878000 |
1.55% |
170000 |
24.01% |
2019-04-30
|
| LF Equity Income |
11171980 |
19.73% |
121000 |
1.09% |
2019-04-30
|
| LF Woodford Income Focus Fund |
878000 |
1.55% |
170000 |
24.01% |
2019-04-30
|
| LF Woodford Equity Income Fund |
11171980 |
19.73% |
121000 |
1.09% |
2019-04-30
|
| T. Rowe Price New Horizons Fund |
302252 |
0.54% |
-13915 |
-4.40% |
2019-03-31
|
| iShares US Small Cap ETF (CAD-Hedged) |
878925 |
1.57% |
-1476 |
-0.17% |
2019-05-30
|
| Vanguard Small Cap Index Fund |
1090228 |
1.94% |
12836 |
1.19% |
2019-04-30
|
| OMIM GBP QI UK Equity Income II |
412341 |
0.73% |
-- |
-- |
2019-01-31
|
| Quilter Investors UK Equity Income II Fd |
412341 |
0.73% |
-- |
-- |
2019-01-31
|
| T. Rowe Price Health Sciences Fund |
565104 |
1.02% |
-60308 |
-9.64% |
2018-09-30
|
| Woodford Patient Capital Trust |
1427893 |
2.58% |
-- |
-- |
2018-01-31
|
| Vanguard Total Stock Mkt Idx |
1003208 |
1.82% |
1150 |
0.11% |
2018-07-31
|
| iShares Nasdaq Biotechnology |
621542 |
1.11% |
-1182 |
-0.19% |
2018-09-12
|
| T. Rowe Price Health Sciences |
625412 |
1.13% |
625412 |
-- |
2018-06-30
|
| Vanguard Small Cap Growth Index Inv |
588035 |
1.07% |
6787 |
1.17% |
2018-07-31
|
| Vanguard Extended Market Idx Inv |
550306 |
1.00% |
3200 |
0.58% |
2018-07-31
|
| iShares Russell 2000 Growth |
411362 |
0.73% |
-397 |
-0.10% |
2018-09-12
|
| T. Rowe Price New Horizons |
366167 |
0.66% |
366167 |
-- |
2018-06-30
|
| State Street Russell Small/Mid Cap Idx Fd Cl I |
135765 |
0.25% |
6914 |
5.37% |
2017-06-30
|
| iShares US Pharmaceuticals |
204164 |
0.36% |
-- |
-- |
2018-09-12
|
| T. Rowe Price QM US Small-Cap Growth Eq |
329029 |
0.60% |
5400 |
1.67% |
2018-06-30
|
| Fidelity Spartan |
188418 |
0.34% |
9464 |
5.29% |
2018-05-31
|
| iShares Russell 2000 (AU) |
407214 |
1.20% |
-516 |
-0.10% |
2015-11-19
|
| CF Woodford Equity Income |
330685 |
1.00% |
30685 |
10.20% |
2015-09-30
|
| SPDR® S&P Pharmaceuticals ETF |
299032 |
0.90% |
-- |
-- |
2015-11-19
|
| Royce Capital Fund Micro-Cap Portfolio |
200700 |
0.60% |
22900 |
12.90% |
2015-09-30
|
| iShares Russell 2000 Value |
171696 |
0.50% |
-- |
-- |
2015-11-19
|
| Royce Micro Cap Series Fund |
161600 |
0.50% |
4100 |
2.60% |
2015-09-30
|
| Oppenheimer Global Fund |
588092 |
1.70% |
-- |
-- |
2015-09-30
|
| VY Oppenheimer Global Portfolio |
100411 |
0.30% |
-- |
-- |
2015-09-30
|
| Oppenheimer Global Fund/VA |
157022 |
0.50% |
-- |
-- |
2015-09-30
|
